Optimizing Transition of Care in Multiple Myeloma: Bridging the Gap Between Academic and Community Settings : Episode 2
Treating Patients Referred to Academic Centers for CAR T
Focusing on the transition of patients from community practices to academic centers, the panel discusses the initial evaluation and treatment processes, focusing on bridging therapy for patients awaiting CAR T.
- From the academic center's perspective, how do you approach the initial consultation and evaluation process for patients referred for CAR T-cell therapy from community practices?
- Are the processes similar across academic settings?
- How do you coordinate care and maintain communication with the academic center during the CAR-T treatment period?
- What is your approach to bridging therapy for patients awaiting CAR-T? How do you decide on the appropriate bridging regimen?
- How closely do you coordinate with academic centers around bridging therapy considerations and processes?
Related Content
Fostering Academic, Community Practice Collaboration for Bispecific Therapy in Multiple Myeloma
December 26th 2024Article
Experts in multiple myeloma spoke about optimal treatment strategies for patients who receive bispecific therapy, focusing specifically on facilitating a multifaceted approach between academic and community practices.
